These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11769528)

  • 41. Regression of low-grade non-Hodgkin's lymphoma after treatment with pegylated interferon plus ribavirin in hepatitis C virus infection.
    Mazzaro C; Spina M; Tirelli U
    J Clin Oncol; 2005 Jul; 23(19):4470-1; author reply 4471. PubMed ID: 15994165
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of hepatitis B virus-associated nephropathy.
    Elewa U; Sandri AM; Kim WR; Fervenza FC
    Nephron Clin Pract; 2011; 119(1):c41-9; discussion c49. PubMed ID: 21677438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B-related membranous nephropathy should be treated with a specific anti-viral agent.
    Tang S; Lai KN
    Kidney Int; 2006 Aug; 70(4):818. PubMed ID: 16900222
    [No Abstract]   [Full Text] [Related]  

  • 44. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute HIV seroconversion in a patient receiving pegylated interferon for treatment of hepatitis C.
    Maser E; Dieterich DT
    AIDS Read; 2003 Jun; 13(6):279-80, 287. PubMed ID: 12846173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Editorial comment: diagnosis of acute HIV infection in hepatitis C treatment nonresponders--is extra vigilance required?
    Golia P; Talal A
    AIDS Read; 2003 Jun; 13(6):288-90. PubMed ID: 12846174
    [No Abstract]   [Full Text] [Related]  

  • 47. Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature.
    Weng Q; Li X; Ren H; Xie J; Pan X; Xu J; Chen N
    Oncotarget; 2017 Mar; 8(13):22299-22303. PubMed ID: 28223549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C virus infection and membranous glomerulonephritis.
    Rollino C; Roccatello D; Giachino O; Basolo B; Piccoli G
    Nephron; 1991; 59(2):319-20. PubMed ID: 1956497
    [No Abstract]   [Full Text] [Related]  

  • 49. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2000 Jun; 32(4):714-6. PubMed ID: 10856556
    [No Abstract]   [Full Text] [Related]  

  • 52. [Two cases of membranous glomerulonephritis associated with hepatitis C virus infection].
    Takishita Y; Ishikawa S; Okada K
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1203-8. PubMed ID: 7815754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
    Shimada M; Yoshida S; Kornek M; Kim SJ; Schuppan D
    Liver Int; 2010 Nov; 30(10):1552-4. PubMed ID: 20557455
    [No Abstract]   [Full Text] [Related]  

  • 54. Care of patients with hepatitis C and HIV co-infection.
    Soriano V; Puoti M; Sulkowski M; Mauss S; Cacoub P; Cargnel A; Dieterich D; Hatzakis A; Rockstroh J
    AIDS; 2004 Jan; 18(1):1-12. PubMed ID: 15090824
    [No Abstract]   [Full Text] [Related]  

  • 55. PSG consensus statement on management of hepatitis C virus infection--2003.
    Hamid S; Umar M; Alam A; Siddiqui A; Qureshi H; Butt J;
    J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
    [No Abstract]   [Full Text] [Related]  

  • 56. [HIV/HCV coinfection: 40% of patients can successfully be treated].
    Dtsch Med Wochenschr; 2004 Apr; 129(16):911. PubMed ID: 15134089
    [No Abstract]   [Full Text] [Related]  

  • 57. Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy.
    Lederer S; Zachoval R; Hasholzner U; Schiffl H
    Clin Nephrol; 2008 Apr; 69(4):313-6. PubMed ID: 18397710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful pegylated interferon alpha2a monotherapy for hepatitis C virus infection in a transplanted patient who relapsed after the preceding course.
    Ichikawa T; Taura N; Miyaaki H; Matsuzaki M; Eguchi S; Takatsuki M; Kanematsu T; Nakao K
    Transpl Infect Dis; 2011 Aug; 13(4):438-40. PubMed ID: 21309967
    [No Abstract]   [Full Text] [Related]  

  • 59. Interferon-alpha induced transient thyroid dysfunction in hepatitis C.
    Fernández-Díez S; Rodríguez-Agulló JL; Cascudo Rielo MJ; Navarro Angulo N; Díaz-Rubio M
    Rev Esp Enferm Dig; 2002 Mar; 94(3):159-63. PubMed ID: 12185880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Epidermolysis bullosa acquisita and hepatitis C].
    Thiery S; Misery L; Chossegros P; Kanitakis J; Ghohestani R; Forestier JY; Trepo C; Faure M; Claudy A
    Ann Dermatol Venereol; 1998 Apr; 125(4):264-7. PubMed ID: 9747265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.